未登录

N

NaiBin Chen

State Key Lab Oncology South China

H指数:9

被引数:274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-10-016

PRE

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-183

OAAI

CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment

基于CT影像组学的局部晚期非小细胞肺癌同步放化疗患者肿瘤及肿瘤机体环境特征的长期生存预测

RADIATION ONCOLOGY

IF3.2

2022-11-1626

OAAI

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-071

OAAI

Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-07-1126

PRE

Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy

RADIOTHERAPY AND ONCOLOGY

IF5.3

2022-03-014

PRE

Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model

RADIOTHERAPY AND ONCOLOGY

IF5.3

2022-02-014

PRE

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-253

OAAI

Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GAST01011)

PRACTICAL RADIATION ONCOLOGY

IF3.5

2021-09-0121

PRE

Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: A phase I trial (GASTO-1021)

RADIOTHERAPY AND ONCOLOGY

IF5.3

2021-02-016

PREAI

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

RADIATION ONCOLOGY

IF3.2

2020-11-109

OAAI

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2020-08-214

OAAI

Differential expression profiles of long noncoding RNAs in synchronous multiple and solitary primary esophageal squamous cell carcinomas: A microarray analysis

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2018-10-155

PREAI